2-Day Course: Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union (London, United Kingdom - February 28-March 1, 2019) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union” conference has been added to ResearchAndMarkets.com’s offering.
This interactive course will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation.
The aim of the course is to provide an overview of recent developments in pharmaceutical regulatory affairs in Russia, the Eurasian Union and the CIS.
The course will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation.
The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will give practical hints on the regulatory process where possible.
Attending this programme will:Give you the full background to the CIS pharmaceutical market Ensure that you understand the full implications of the new regulations which will affect how you do business in the Eurasian Economic Union (EAEU) Help clarify the document requirements and timelines of national procedures and EAEU registration procedures Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries
Introduction and welcome
Russia - competitive landscapeCurrent market and projected growth Pharma-2020 and Health-2020 State programmes Pricing and reimbursement Patent and data protection
Clinical trials in Russia and CISRussia and CIS in global clinical research Clinical trial requirements Local registrations trials in Russia, CIS and the Eurasian Union
Marketing authorisations in RussiaRegulatory authorities in Russia Key regulations governing the MAA process Registration procedures Application dossier requirements
CIS - regional regulatory overviewCIS pharmaceutical market CIS regional regulation co-operation - the Eurasian Union CIS regulatory barriers for Market Access
Marketing authorisations in CISNew Eurasian MAA procedure Common regional requirements in CIS
Workshop - CIS Regional Regulatory Strategy
For more information about this conference visit https://www.researchandmarkets.com/research/73hbh7/2day_course?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005536/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Discovery
KEYWORD: UNITED KINGDOM EUROPE RUSSIA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/22/2019 08:28 AM/DISC: 01/22/2019 08:28 AM